Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001641172-25-025900
Filing Date
2025-08-29
Accepted
2025-08-29 09:00:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5036
  Complete submission text file 0001641172-25-025900.txt   6849
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Subject) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: SCHEDULE 13G | Act: 34 | File No.: 005-35386 | Film No.: 251276467
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139
Business Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139 786-381-2877
Lincoln Alternative Strategies LLC (Filed by) CIK: 0002043812 (see all company filings)

EIN.: 991727271 | State of Incorp.: DE | Fiscal Year End: 0324
Type: SCHEDULE 13G